Related references
Note: Only part of the references are listed.ApoE Induces Serum Paraoxonase PON1 Activity and Stability Similar to ApoA-1
Leonid Gaidukov et al.
BIOCHEMISTRY (2010)
Di-oleoyl phosphatidylcholine (PC-18:1) stimulates paraoxonase 1 (PON1) enzymatic and biological activities: In vitro and in vivo studies
Michal Efrat et al.
ATHEROSCLEROSIS (2009)
Directed Evolution of Serum Paraoxonase PON3 by Family Shuffling and Ancestor/Consensus Mutagenesis, and Its Biochemical Characterization
Olga Khersonsky et al.
BIOCHEMISTRY (2009)
Associations of Adiponectin with Paraoxonase 1 and sE-Selectin in Hemodialyzed Patients
Attila Peti et al.
KIDNEY & BLOOD PRESSURE RESEARCH (2009)
Characterization of the PON1 active site using modeling simulation, in relation to PON1 lactonase activity
Hagai Tavori et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2008)
Consumption of wonderful variety pomegranate juice and extract by diabetic patients increases paraoxonase 1 association with high-density lipoprotein and stimulates its catalytic activities
Wasseem Rock et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2008)
Acrolein inactivates paraoxonase 1: changes in free acrolein levels after hemodialysis correlate with increases in paraoxonase 1 activity in chronic renal failure patients
Alejandro Gugliucci et al.
CLINICA CHIMICA ACTA (2007)
Paraoxonase-1 concentrations in end-stage renal disease patients increase after hemodialysis: Correlation with low molecular AGE adduct clearance
Alejandro Gugliucci et al.
CLINICA CHIMICA ACTA (2007)
The histidine 115-histidine 134 dyad mediates the lactonase activity of mammalian serum paraoxonases
O Khersonsky et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
The catalytic histidine dyad of high density lipoprotein-associated serum paraoxonase-1 (PON1) is essential for PON1-mediated inhibition of low density lipoprotein oxidation and stimulation of macrophage cholesterol efflux
M Rosenblat et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Chromogenic and fluorogenic assays for the lactonase activity of serum paraoxonases
O Khersonsky et al.
CHEMBIOCHEM (2006)
Paraoxonases and cardiovascular diseases: pharmacological and nutritional influences
M Aviram et al.
CURRENT OPINION IN LIPIDOLOGY (2005)
Pathophysiology of cardiovascular disease and renal failure
R Dikow et al.
CARDIOLOGY CLINICS (2005)
Evaluation and treatment of coronary artery disease in patients with end-stage renal disease
PA McCullough
KIDNEY INTERNATIONAL (2005)
Paraoxonases 1, 2, and 3, oxidative stress, and macrophage foam cell formation during atherosclerosis development
M Aviram et al.
FREE RADICAL BIOLOGY AND MEDICINE (2004)
Paraoxonase activity and paraoxonase 1 gene polymorphism in patients with uremia
S Biasioli et al.
ASAIO JOURNAL (2003)
Share Paper
